Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study
2022 · European Journal of Cancer · 56 citations
https://doi.org/10.1016/j.ejca.2022.02.026
R
Rawa K. Ismail
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
319
Citations
10
h-index
10
i10-index
Rawa K. Ismail is an academic researcher. The author has contributed to research in topics: Cutaneous Melanoma Detection and Management & Cancer Immunotherapy and Biomarkers & CAR-T cell therapy research. The author has an h-index of 10, co-authored 29 publications.
ORCID: 0000-0002-0838-0349Papers by this author
worksAdjuvant treatment for melanoma in clinical practice – Trial versus reality
2021 · European Journal of Cancer · 32 citations
https://doi.org/10.1016/j.ejca.2021.08.044
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
2023 · Cancers · 4 citations
https://doi.org/10.3390/cancers15112922
Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?
2022 · The Breast · 1 citations
https://doi.org/10.1016/j.breast.2022.01.011
28 Comparison of Genetic Alteration Concordance Rates: Liquid biopsy vs Conventional biopsy in Non-Small Cell Lung Cancer
2025 · Lung Cancer · 0 citations
https://doi.org/10.1016/j.lungcan.2025.108139
22 Challenges in Meeting Molecular Testing Turnaround Times in Lung Cancer
2025 · Lung Cancer · 0 citations
https://doi.org/10.1016/j.lungcan.2025.108133
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat